Determinants of near fatality in acute severe asthma.

[1]  E. Robin,et al.  Sudden cardiac death in bronchial asthma, and inhaled beta-adrenergic agonists. , 1992, Chest.

[2]  Arthur S Slutsky,et al.  The fatality-prone asthmatic patient. Follow-up study after near-fatal attacks. , 1992, Chest.

[3]  Pierre Ernst,et al.  The Use of β-Agonists and the Risk of Death and near Death from Asthma , 1992 .

[4]  M. Lebowitz,et al.  The beta-agonist dilemma. , 1992, The New England journal of medicine.

[5]  M. Sears.  International trends in asthma mortality. , 1991, Allergy proceedings : the official journal of regional and state allergy societies.

[6]  K. Offord,et al.  Exposure to an aeroallergen as a possible precipitating factor in respiratory arrest in young patients with asthma. , 1991, The New England journal of medicine.

[7]  J Crane,et al.  Prescribed fenoterol and death from asthma in New Zealand, 1981-7: a further case-control study. , 1991, Thorax.

[8]  Arthur S Slutsky,et al.  Respiratory arrest in near-fatal asthma , 1991 .

[9]  C. Print,et al.  Regular inhaled beta-agonist treatment in bronchial asthma , 1990, The Lancet.

[10]  I. Pavord,et al.  Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma , 1990, The Lancet.

[11]  C. van Weel,et al.  Increased bronchial hyperresponsiveness after inhaling salbutamol during 1 year is not caused by subsensitization to salbutamol. , 1990, The Journal of allergy and clinical immunology.

[12]  M. Schaller,et al.  Sudden asphyxic asthma: a distinct entity? , 1990, The American review of respiratory disease.

[13]  M. Petrini,et al.  Mechanical ventilation in patients with acute severe asthma. , 1990, The American journal of medicine.

[14]  K. Weiss.  Seasonal trends in US asthma hospitalizations and mortality. , 1990, JAMA.

[15]  N. Pearce,et al.  Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81. , 1990, Thorax.

[16]  J. Wasserfallen.  Sudden asphyxic asthma , 1990 .

[17]  H. Frankoff.  Circannual variation of human mortality in Texas. , 1990, Progress in clinical and biological research.

[18]  R. Nicklas.  Perspective on asthma mortality--1989. , 1989, Annals of allergy.

[19]  H. Markowe,et al.  Aminophylline toxicity--how many hospital asthma deaths does it cause? , 1989, Respiratory medicine.

[20]  N. Pearce,et al.  PRESCRIBED FENOTEROL AND DEATH FROM ASTHMA IN NEW ZEALAND, 1981-83; CASE-CONTROL STUDY , 1989, The Lancet.

[21]  R. Pauwels.  New aspects of the therapeutic potential of theophylline in asthma. , 1989, The Journal of allergy and clinical immunology.

[22]  Sly Rm.  Mortality from asthma, 1979–1984 , 1988 .

[23]  M. Sears,et al.  International trends in asthma mortality: 1970 to 1985. , 1988, Chest.

[24]  C. Bucknall,et al.  Management of asthma in hospital: a prospective audit , 1988, British medical journal.

[25]  F. Moran,et al.  DIFFERENCES IN HOSPITAL ASTHMA MANAGEMENT , 1988, The Lancet.

[26]  E. Robin,et al.  Death from bronchial asthma. , 1988, Chest.

[27]  L. Reid.  The presence or absence of bronchial mucus in fatal asthma. , 1987, The Journal of allergy and clinical immunology.

[28]  D. Poynter.  Fatal asthma--is treatment incriminated? , 1987, The Journal of allergy and clinical immunology.

[29]  M. Sears,et al.  Use of anti-asthma drugs in New Zealand. , 1987, Thorax.

[30]  R. Nicklas,et al.  Adverse effects of theophylline-beta agonist interactions. , 1986, The Journal of allergy and clinical immunology.

[31]  Sly Rm.  Effects of treatment on mortality from asthma. , 1986 .

[32]  H. Sluiter,et al.  Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: a comparison between budesonide and terbutaline. , 1985, The Journal of allergy and clinical immunology.

[33]  G. Sieck,et al.  Aminophylline and its influence on ventilatory endurance in humans. , 1985, The American review of respiratory disease.

[34]  M. Aubier,et al.  Effects of theophylline on diaphragmatic strength and fatigue in patients with chronic obstructive pulmonary disease. , 1984, The New England journal of medicine.

[35]  J. Wilson,et al.  HAS THE CHANGE TO BETA-AGONISTS COMBINED WITH ORAL THEOPHYLLINE INCREASED CASES OF FATAL ASTHMA? , 1981, The Lancet.

[36]  A. Rubinfeld,et al.  PERCEPTION OF ASTHMA , 1976, The Lancet.

[37]  W. Segar,et al.  Elevated plasma antidiuretic hormone levels in status asthmaticus. , 1976, Mayo Clinic proceedings.

[38]  J. Bradshaw,et al.  Medical audit , 1975, The Lancet.

[39]  A. Steinberg,et al.  Letter: Lymphoid malignancy. , 1974, Lancet.

[40]  F. Speizer,et al.  Investigation into use of drugs preceding death from asthma. , 1968, British medical journal.

[41]  S. Siegel,et al.  Nonparametric Statistics for the Behavioral Sciences , 2022, The SAGE Encyclopedia of Research Design.